EDGAR Filing Documents for 0001144204-17-019259

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001144204-17-019259

Filing Date

2017-04-05

Accepted

2017-04-05 17:19:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 3	v463638_f1a3.htm	F-1/A	37252
2	EXHIBIT 1.1	v463638_ex1-1.htm	EX-1.1	251569
3	EXHIBIT 4.1	v463638_ex4-1.htm	EX-4.1	106585
4	EXHIBIT 4.2	v463638_ex4-2.htm	EX-4.2	103355
5	EXHIBIT 5.1	v463638_ex5-1.htm	EX-5.1	9557
6	EXHIBIT 5.2	v463638_ex5-2.htm	EX-5.2	10873
7	GRAPHIC	pg1img1_ex5-2.jpg	GRAPHIC	14373
8	GRAPHIC	pg1img2_ex5-2.jpg	GRAPHIC	12122
	Complete submission text file	0001144204-17-019259.txt		557072

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042

Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616

Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)